Assembly of intercellular junctions in epithelial cell monolayers following exposure to cryoprotectants.
We investigated the effects of cryoprotectants (glycerol, propane-1, 2-diol, dimethyl sulfoxide) on the ability of epithelial cells to assemble intercellular junctions. Madin-Darby canine kidney cells (MDCK, type II) were grown in S-MEM containing only 5 micromol/L Ca(2+) to allow attachment of cells to the growth surface but not the development of the junctional complex. In a first set of experiments, cells were exposed to 10% v/v cryoprotectant at room temperature for 30 min. After removal of the cryoprotectant, [Ca(2+)] was increased to 1.8 mmol/L (Ca-switch) and the assembly of junctions was followed immunocytochemically and by monitoring transepithelial resistance (TER). In a second set of experiments, the development of junctions was followed in the presence of 1% cryoprotectant. Addition and removal of 10% cryoprotectant had little effect on the assembly of junctions following the Ca-switch, with TER peaking >300 ohm cm(2) after 24 h. Immunocytochemical staining showed recruitment to cell borders of components of tight junctions, adherens junctions, and desmosomes and the presence of a distinct circumferential bundle of actin filaments. In the presence of 1% cryoprotectant, there was a lag of more than 20 h before TER began to rise. There was then a progressive rise in TER in all three cryoprotectant groups, indicating junction assembly, albeit at a lower rate than that in the absence of cryoprotectant. These results suggest that exposure to cryoprotectants per se will not inhibit cellular repair mechanisms aimed at restoring the integrity of epithelial cell layers, but incomplete removal of cryoprotectant may delay repair.
Armitage
W J
WJ
Division of Ophthalmology, University of Bristol, Bristol BS1 2LX, United Kingdom.
Juss
B K
BK
D008841:Actin Cytoskeleton / Q000737:chemistry / Q000648:ultrastructure; D000199:Actins / Q000032:analysis; D022005:Adherens Junctions / Q000737:chemistry / Q000187:drug effects / Q000648:ultrastructure; D000818:Animals; D015820:Cadherins / Q000032:analysis; D002460:Cell Line / Q000187:drug effects / Q000648:ultrastructure; D003451:Cryoprotective Agents / Q000494:pharmacology*; D003598:Cytoskeletal Proteins / Q000032:analysis; D051180:Desmoplakins; D003896:Desmosomes / Q000737:chemistry / Q000187:drug effects / Q000648:ultrastructure; D004121:Dimethyl Sulfoxide / Q000494:pharmacology*; D004285:Dogs; D004847:Epithelial Cells / Q000737:chemistry / Q000187:drug effects* / Q000648:ultrastructure; D005990:Glycerol / Q000494:pharmacology*; D007365:Intercellular Junctions / Q000737:chemistry / Q000187:drug effects* / Q000648:ultrastructure; D007668:Kidney; D008564:Membrane Potentials / Q000187:drug effects; D008565:Membrane Proteins / Q000032:analysis; D010750:Phosphoproteins / Q000032:analysis; D019946:Propylene Glycol / Q000494:pharmacology*; D062826:Zonula Occludens-1 Protein
D000199:Actins; D015820:Cadherins; D003451:Cryoprotective Agents; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D008565:Membrane Proteins; D010750:Phosphoproteins; D062826:Zonula Occludens-1 Protein; D019946:Propylene Glycol; D005990:Glycerol; D004121:Dimethyl Sulfoxide